Detalles de la búsqueda
1.
Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non-Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175.
Oncologist
; 29(1): 47-56, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37390616
2.
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.
Oncologist
; 28(11): 1007-e1107, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37555284
3.
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 23(2): 279-291, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35033226
4.
Do Patients Regret Having Received Systemic Treatment for Advanced Non-Small Cell Lung Cancer: A Prospective Evaluation.
Oncologist
; 26(3): 224-230, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098189
5.
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.
Cancer
; 126(19): 4353-4361, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32697352
6.
Intracranial disease control for EGFR-mutant and ALK-rearranged lung cancer with large volume or symptomatic brain metastases.
J Neurooncol
; 149(2): 357-366, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32902767
7.
Striving toward Improved Outcomes for Surgically Resectable Non-Small Cell Lung Cancer: the Promise and Challenges of Neoadjuvant Immunotherapy.
Curr Oncol Rep
; 22(11): 109, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32803520
8.
Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
Support Care Cancer
; 26(7): 2353-2359, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29417293
9.
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.
Lancet Oncol
; 17(11): 1497-1508, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27745820
10.
Complex decisions for first-line and maintenance treatment of advanced wild-type non-small cell lung cancer.
Oncologist
; 20(3): 299-306, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25660158
11.
The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.
Cancer
; 120(24): 3853-8, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25155290
12.
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
Br J Haematol
; 165(6): 793-800, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24628515
13.
Optimal first-line and maintenance treatments for advanced-stage nonsquamous non-small cell lung cancer.
J Natl Compr Canc Netw
; 12(6): 889-97, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24925199
14.
Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Curr Oncol
; 31(1): 260-273, 2024 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38248102
15.
Bevacizumab in advanced NSCLC: chemotherapy partners and duration of use.
Curr Treat Options Oncol
; 14(4): 595-609, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23990213
16.
Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain Metastases.
Cancers (Basel)
; 15(12)2023 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37370865
17.
Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy.
Front Oncol
; 12: 986236, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36212442
18.
A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139.
Clin Lung Cancer
; 23(7): 578-584, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36041949
19.
Replicative Instability Drives Cancer Progression.
Biomolecules
; 12(11)2022 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36358918
20.
Bayesian Design for Identifying Cohort-Specific Optimal Dose Combinations Based on Multiple Endpoints: Application to a Phase I Trial in Non-Small Cell Lung Cancer.
Int J Environ Res Public Health
; 18(21)2021 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34769970